Target raised today from $11 to $12 by Oppenheimer...
Popped up on my Ameritrade Keryx summary page. Another strong indicator of higher prices to come. Apparently they had a private meeting with Ron and management and came away very impressed. If yoou're not buying here---what are you waiting for. When options expire today, it's off to the races in the next couple of weeks. I don't know why ANYONE would be selling here.
Here is the press release:
UPDATE: Oppenheimer Raises PT on Keryx Biopharmaceuticals Following Management Meetings
11:11a ET May 17, 2013 (Benzinga) In a report published Friday, Oppenheimer analyst Boris Peaker reiterated an Outperform rating on Keryx Biopharmaceuticals (NASDAQ: KERX), and slightly raised the price target from $11.00 to $12.00.
In the report, Peaker noted, “We recently met with management and had an opportunity to probe further into the clinical and pre-commercial developments for Zerenex. The update confirms our bullish view on the drug and provides incremental data points that may be overlooked by some investors. We continue to believe that Zerenex is a commercially attractive phosphate binder that has multiple advantages compared to the competition, and we anticipate the drug will gain approval in 1H13. We revised our NPV model and are raising our price target on Keryx to $12/share from $11 while maintaining our Outperform rating.”
Keryx Biopharmaceuticals closed on Thursday at $8.00.